Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Mavroudis D, Saloustros E, Malamos N, Kakolyris S, Boukovinas I, Papakotoulas P. et al.
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: A multicenter randomized study by the Hellenic Oncology Research Group (HORG).

Ann Oncol 2015;
26: 1333-40

Bibliographische Angaben herunterladen

Aufrufen in: